ArticleTherapeutic advances in neurological disorders2025

Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study.

Hye Lim Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.